Robert Clarke, John F Peden, Jemma C Hopewell, Theodosios Kyriakou, Anuj Goel, Simon C Heath, Sarah Parish, Simona Barlera, Maria Grazia Franzosi, Stephan Rust, Derrick Bennett, Angela Silveira, Anders Malarstig, Fiona R Green, Mark Lathrop, Bruna Gigante, Karin Leander, Ulf de Faire, Udo Seedorf, Anders Hamsten, Rory Collins, Hugh Watkins, Martin Farrall. N Engl J Med 2009
Times Cited: 873
Times Cited: 873
Eberhard Roeseler, Ulrich Julius, Franz Heigl, Ralf Spitthoever, Dennis Heutling, Paul Breitenberger, Josef Leebmann, Walter Lehmacher, Pia R Kamstrup, Børge G Nordestgaard, Winfried Maerz, Asma Noureen, Konrad Schmidt, Florian Kronenberg, Andreas Heibges, Reinhard Klingel. Arterioscler Thromb Vasc Biol 2016
Times Cited: 114
Times Cited: 114
List of shared articles
Times cited
Global think tank on the clinical considerations and management of lipoprotein(a): The top questions and answers regarding what clinicians need to know.
Salim S Virani, Marlys L Koschinsky, Lisa Maher, Anurag Mehta, Carl E Orringer, Raul D Santos, Michael D Shapiro, Joseph J Saseen. Prog Cardiovasc Dis 2022
Salim S Virani, Marlys L Koschinsky, Lisa Maher, Anurag Mehta, Carl E Orringer, Raul D Santos, Michael D Shapiro, Joseph J Saseen. Prog Cardiovasc Dis 2022
Lipoprotein(a): a risk factor for atherosclerosis and an emerging therapeutic target.
Stefania Angela Di Fusco, Marcello Arca, Pietro Scicchitano, Alessandro Alonzo, Francesco Perone, Michele Massimo Gulizia, Domenico Gabrielli, Fabrizio Oliva, Giuseppe Imperoli, Furio Colivicchi. Heart 2022
Stefania Angela Di Fusco, Marcello Arca, Pietro Scicchitano, Alessandro Alonzo, Francesco Perone, Michele Massimo Gulizia, Domenico Gabrielli, Fabrizio Oliva, Giuseppe Imperoli, Furio Colivicchi. Heart 2022
The long journey of lipoprotein(a) from cardiovascular curiosity to therapeutic target.
Marlys L Koschinsky, Florian Kronenberg. Atherosclerosis 2022
Marlys L Koschinsky, Florian Kronenberg. Atherosclerosis 2022
Lipoprotein (a) as a treatment target for cardiovascular disease prevention and related therapeutic strategies: a critical overview.
Ioannis Parthymos, Michael S Kostapanos, Dimitri P Mikhailidis, Matilda Florentin. Eur J Prev Cardiol 2022
Ioannis Parthymos, Michael S Kostapanos, Dimitri P Mikhailidis, Matilda Florentin. Eur J Prev Cardiol 2022
Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association.
Gissette Reyes-Soffer, Henry N Ginsberg, Lars Berglund, P Barton Duell, Sean P Heffron, Pia R Kamstrup, Donald M Lloyd-Jones, Santica M Marcovina, Calvin Yeang, Marlys L Koschinsky. Arterioscler Thromb Vasc Biol 2022
Gissette Reyes-Soffer, Henry N Ginsberg, Lars Berglund, P Barton Duell, Sean P Heffron, Pia R Kamstrup, Donald M Lloyd-Jones, Santica M Marcovina, Calvin Yeang, Marlys L Koschinsky. Arterioscler Thromb Vasc Biol 2022
Lipoprotein(a) and Cardiovascular Disease: A Missing Link for Premature Atherosclerotic Heart Disease and/or Residual Risk.
Helen Melita, Antonis A Manolis, Theodora A Manolis, Antonis S Manolis. J Cardiovasc Pharmacol 2022
Helen Melita, Antonis A Manolis, Theodora A Manolis, Antonis S Manolis. J Cardiovasc Pharmacol 2022
Lipoprotein(a) levels from childhood to adulthood: Data in nearly 3,000 children who visited a pediatric lipid clinic.
Lotte M de Boer, Michel H Hof, Albert Wiegman, An K Stroobants, John J P Kastelein, Barbara A Hutten. Atherosclerosis 2022
Lotte M de Boer, Michel H Hof, Albert Wiegman, An K Stroobants, John J P Kastelein, Barbara A Hutten. Atherosclerosis 2022
The impact of race and ethnicity on lipoprotein(a) levels and cardiovascular risk.
Gissette Reyes-Soffer. Curr Opin Lipidol 2021
Gissette Reyes-Soffer. Curr Opin Lipidol 2021
Genetics of Lipoprotein(a): Cardiovascular Disease and Future Therapy.
Anne Langsted, Børge G Nordestgaard. Curr Atheroscler Rep 2021
Anne Langsted, Børge G Nordestgaard. Curr Atheroscler Rep 2021